JP2017506257A5 - - Google Patents

Download PDF

Info

Publication number
JP2017506257A5
JP2017506257A5 JP2016558543A JP2016558543A JP2017506257A5 JP 2017506257 A5 JP2017506257 A5 JP 2017506257A5 JP 2016558543 A JP2016558543 A JP 2016558543A JP 2016558543 A JP2016558543 A JP 2016558543A JP 2017506257 A5 JP2017506257 A5 JP 2017506257A5
Authority
JP
Japan
Prior art keywords
compound
agx51
substituted
dioxol
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016558543A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017506257A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/070221 external-priority patent/WO2015089495A2/en
Publication of JP2017506257A publication Critical patent/JP2017506257A/ja
Publication of JP2017506257A5 publication Critical patent/JP2017506257A5/ja
Pending legal-status Critical Current

Links

JP2016558543A 2013-12-13 2014-12-14 癌及びその他の増殖性疾患の治療、予防及び診断のための組成物並びに方法 Pending JP2017506257A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361916116P 2013-12-13 2013-12-13
US61/916,116 2013-12-13
US201461965776P 2014-02-06 2014-02-06
US61/965,776 2014-02-06
PCT/US2014/070221 WO2015089495A2 (en) 2013-12-13 2014-12-14 Compositions and methods for treating, preventing and diagnosing cancer and other proliferative disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019162598A Division JP2019203028A (ja) 2013-12-13 2019-09-06 癌及びその他の増殖性疾患の治療、予防及び診断のための組成物並びに方法

Publications (2)

Publication Number Publication Date
JP2017506257A JP2017506257A (ja) 2017-03-02
JP2017506257A5 true JP2017506257A5 (enrdf_load_stackoverflow) 2018-02-01

Family

ID=53371974

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016558543A Pending JP2017506257A (ja) 2013-12-13 2014-12-14 癌及びその他の増殖性疾患の治療、予防及び診断のための組成物並びに方法
JP2019162598A Withdrawn JP2019203028A (ja) 2013-12-13 2019-09-06 癌及びその他の増殖性疾患の治療、予防及び診断のための組成物並びに方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019162598A Withdrawn JP2019203028A (ja) 2013-12-13 2019-09-06 癌及びその他の増殖性疾患の治療、予防及び診断のための組成物並びに方法

Country Status (6)

Country Link
EP (1) EP3079680A4 (enrdf_load_stackoverflow)
JP (2) JP2017506257A (enrdf_load_stackoverflow)
CN (1) CN107847470A (enrdf_load_stackoverflow)
AU (1) AU2014361814A1 (enrdf_load_stackoverflow)
MX (1) MX2016007748A (enrdf_load_stackoverflow)
WO (1) WO2015089495A2 (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000548B2 (en) * 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
CA2982452A1 (en) 2015-04-21 2016-10-27 Enlivex Therapeutics Ltd. Therapeutic pooled blood apoptotic cell preparations and uses thereof
AU2017219415B2 (en) 2016-02-18 2023-08-10 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment
LU100900B1 (de) * 2018-08-10 2020-02-17 Thomas Melchior Homann Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen
EP3760614B8 (en) * 2019-07-02 2022-04-27 Universität Heidelberg Chemical inhibitors of id proteins for the treatment of cancer and other diseases
JP2022550589A (ja) * 2019-10-01 2022-12-02 メモリアル スローン ケタリング キャンサー センター Idタンパク質の小分子阻害剤
CN113627763B (zh) * 2021-07-30 2023-12-01 厦门大学 一种风险量化评估模型建立方法
CN114480490A (zh) * 2021-12-31 2022-05-13 四川省医学科学院·四川省人民医院 一种构建视网膜新生血管性疾病动物模型的方法
CN115487358B (zh) * 2022-08-05 2023-05-30 核工业四一六医院 一种用于软骨组织修复的凝胶复合支架及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8138356B2 (en) * 2007-10-16 2012-03-20 Angiogeney, Inc. Chemical inhibitors of inhibitors of differentiation
US20130171158A1 (en) * 2010-06-30 2013-07-04 Garvan Institute Of Medical Research Treatment of abnormalities of glucose metabolism with an antagonist of inhibitor of differentiation 1
WO2013025939A2 (en) * 2011-08-16 2013-02-21 Indiana University Research And Technology Corporation Compounds and methods for treating cancer by inhibiting the urokinase receptor

Similar Documents

Publication Publication Date Title
JP2017506257A5 (enrdf_load_stackoverflow)
US10246406B2 (en) Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
AU2016256471B2 (en) Methods of treating cancer
CN103998035B (zh) 包含格列酮和nrf2激活剂的药物组合物
TWI791507B (zh) 使用ccr3-抑制劑治療老化相關損傷之方法及組合物
JP7262118B2 (ja) 医薬組成物およびその使用
ES2896735T3 (es) Eflornitina para su uso en el tratamiento del astrocitoma anaplásico recurrente/refractario por temozolomida
JP2016516074A5 (enrdf_load_stackoverflow)
BRPI1013259B1 (pt) Moduladores lxr
JP2008528489A (ja) Qt間隔調節方法
JP2014515407A5 (enrdf_load_stackoverflow)
CN114025766A (zh) 用于抑制gapdh的噁噻嗪化合物
AU2019274870B2 (en) Method of treating pain or interstitial cystitis using indole compound
US20220395577A1 (en) Methods and materials for modulating nrf2 pathway
WO2021066136A1 (ja) 筋ジストロフィー治療薬
US11389434B2 (en) Methods and pharmaceutical compositions for the treatment of mast cell diseases
JP2014505074A5 (enrdf_load_stackoverflow)
JPH09500375A (ja) パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用
WO2019211783A1 (en) Indoleamine 2,3-dioxygenase signalling modulator and therapeutic use thereof
WO2024095118A1 (en) Dosing regimen of a csf-1r inhibitor for use in the treatment of amyotrophic lateral sclerosis
HK40067738A (en) Oxathiazin compounds for inhibiting gapdh
HK40049577B (en) Indole compound for treating interstitial cystitis
HK40049577A (en) Indole compound for treating interstitial cystitis
JP2020522565A (ja) プロスタグランジンe2の生成を阻害する多置換されたピリミジン、その製造方法およびその使用